G2-PASE approximates PASI using routinely captured PGA and BSA, aiming to replace impractical PASI scoring in real-world clinical settings without sacrificing measurement fidelity. Strong performance ...

DMB-3115 showed similar efficacy and safety to ustekinumab in a phase 3 trial for plaque psoriasis, with comparable PASI score reductions. The study involved 598 patients, with no clinically ...

HORSHAM, PA — STRATA Skin Sciences Inc. (Nasdaq: SSKN) highlighted a February 2026 systematic review and meta-analysis that ...

Behavioral, pharmacological, and surgical weight loss interventions among adults with psoriasis is associated with significant improvements in Psoriasis Area and Severity Index scores compared with ...